See the DrugPatentWatch profile for Tnkase
What is TNKase (tenecteplase), and what dose is used?
TNKase is tenecteplase, a thrombolytic medicine. The dosing depends on the condition being treated and the patient’s weight. [1]
How is TNKase dosed by weight for acute myocardial infarction?
For acute myocardial infarction, the TNKase dose is given as a single intravenous (IV) bolus with weight-based dosing. [1]
Your prescriber’s order should specify the exact milligrams based on the patient’s weight, and TNKase is typically administered as a one-time bolus rather than an infusion. [1]
How is TNKase dosed for ischemic stroke?
Tenecteplase dosing for ischemic stroke is also weight-based, but the exact mg amount differs from other indications. [1]
How is TNKase typically administered (bolus vs infusion)?
TNKase is administered IV; for the commonly referenced indications, it is delivered as an IV bolus rather than a prolonged infusion. [1]
What dosing limits or adjustments should clinicians consider?
Dose selection for TNKase is based on weight, and the product labeling includes specific dosing ranges and maximum dose guidance for safety. [1]
What happens if the dose is missed or given incorrectly?
Because TNKase is a thrombolytic, incorrect dosing can increase bleeding risk or reduce efficacy. If a dose error is suspected, clinicians generally follow hospital protocols for medication errors and rapidly reassess whether to continue, correct the dose, or monitor and treat complications—especially bleeding. (Specific steps are not provided in the available source text.) [1]
---
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103634